The US Food and Drug Administration (FDA) has approved a groundbreaking blood test that can detect brain plaques linked to Alzheimer’s disease, offering a safer and more accessible diagnostic tool. The non-invasive test is designed to identify amyloid plaques in the brains of patients exhibiting symptoms, providing an early warning system for this neurodegenerative condition.
Source: https://www.washingtonpost.com/business/2025/05/16/alzheimers-blood-test-fda-approved